Study of ACTR T Cell Product in Combination With Trastuzumab in Subjects With HER2-Positive Advanced Solid Tumor Cancers
Clinical trial NCT03680560 · TERMINATED
Trial details
- NCT number
- NCT03680560
- Sponsor
- Cogent Biosciences, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-13
- Primary completion
- 2020-03-12
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.